2 min read
Testing Medical Devices with Artificial Anatomy Models
Whether you’re a new medtech startups or established strategic, testing new devices against realistic anatomical conditions is crucial for...
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
4 min read
Jess Willing-Pichs
:
Sep 24, 2025 10:24:05 AM
Author: Jess Willing-Pichs
The push shows no signs of slowing down. Hospitals are discharging patients faster, payers are looking for cost reductions, and patients themselves are choosing the comfort of their own homes and beds over hospital rooms. The home care market continues to grow, with current estimates valuing the global home medical device market at $43.35 billion in 2024, projected to reach $75.04 billion by 2032. But success requires more than simply repackaging clinical solutions for the living room.
Several forces are converging to create unprecedented demand for medical devices in the home setting:
Here's what many innovators miss: the home is not a mini-hospital. It's a fundamentally different environment with different users, different workflows, different risks, and different success factors for medical devices at home.
In clinical settings, your user is frequently a registered clinician with specialized training and has colleagues nearby for support. At home? Your user might be a 75-year-old patient with arthritis, poor eyesight, high school diploma and no medical training, trying to manage their own IV infusion while their cat jumps on their lap, the kettle is whistling and the TV is on.
This isn't about planning for outliers. This is a primary use case.
Power and Placement: Hospital rooms have accessible outlets every few feet. Home outlets hide behind heavy sofas, already occupied by five other plugs, connected through questionable extension cords. Your device's battery life isn't a nice-to-have; it's essential.
Alarms and Alerts: That piercing low-battery alarm designed to cut through hospital noise? It's now terrifying an elderly patient home alone who doesn't understand what it means or how to respond.
The Patient Paradox: Here's what surprises many teams: patients at home don't think of themselves as patients. They're parents who need to do laundry and make dinner, professionals taking video calls, people living their lives. They forget they're tethered to medical devices at home. They stand up quickly to answer the door or grab a snack. They navigate stairs, carry groceries, and read stories to grandchildren on their lap.
Our recent research across multiple home drug combination device-based studies over the past 24 months has revealed a crucial insight: the biggest barrier for patients isn't the injection itself, it's confidence. Patients second-guess themselves mid-injection. "Am I doing this right? How long do I hold the device steady for? Is the device working correctly? When is it safe to remove it?"
Traditional solutions (such as pre-discharge patient education and paper-based instruction manuals) fall short because the next injection might be a month later when memories have faded and anxiety has built.
Design for confidence at every touchpoint. This means:
Patients receiving home infusions have heightened safety concerns (it's an IV line directly into their vein) but they also want to move freely in their own homes.
The companies succeeding with medical devices at home aren't those with the most advanced technology; they're those who deeply understand the home context and design deliberately for it. This requires:
The shift to home care represents one of healthcare's most significant opportunities. But success with medical devices at home requires more than adapting existing solutions. It demands reimagining your device through the lens of where and how it will actually be used.
The question isn't whether your technology can work at home. It's whether you've designed it to thrive there.
Ready to explore how your medical device can successfully transition to home care? The Veranex Research & Strategy team specializes in translating clinical innovations into home-ready solutions, leveraging deep ethnographic research and human factors expertise to ensure patients can confidently use your device where it matters most.
Jess Willing-Pichs is a principal in the Research and Strategy group at Veranex. Our research and strategy experts pinpoint the crucial intersection of User & Stakeholder Desirability, Commercial & Business Viability, and Science & Technology Feasibility. This comprehensive analysis delivers the clarity and actionable intelligence essential for confident a new medical device innovation that truly matters.
¹Business Research Insights. "Home Medical Device Market Report (2024-2032)."
2 min read
Whether you’re a new medtech startups or established strategic, testing new devices against realistic anatomical conditions is crucial for...
Four Advantages In-House Histopathology Labs Give Medical Device Innovators a Critical Edge For medical devices, histopathology serves as the gold...
Vigilance reporting and postmarket surveillance of medical devices are among the many requirements documented in the EU MDR (2017/745) to ensure the...